Mindfulness-based therapy to ease distress and build self-compassion in people with psoriasis
Tests mindfulness-based cognitive therapy for distress and self-compassion in people with psoriasis.
Plain-language title generated from the registry record
Registry title: Managing Psychological Distress Through Mindfulness-based CBT to Evaluate Its Effectiveness on Self-compassion Among Psoriasis Patients:The Mediating Role of Mental Health Locus of Control
Key facts
- Where
- Rahim Yar Khan, PakistanSee the site
AI summary: who the study is looking for
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with psoriasis who feel psychological distress. It tests mindfulness-based cognitive therapy (MBCT) against usual care.
- Age
- The inclusion criteria say 18 to 65 years. The registry age fields say 25 to 75 years.
- Sex
- Men and women can join.
- Disease stage
- Diagnosed psoriasis with psychological distress. No stage or severity is given.
- Earlier treatment
- People currently receiving other psychological therapies cannot join.
Main reasons for not taking part
- Severe psychiatric disorders
- Currently receiving other psychological therapies
- Serious medical or neurological conditions
- Cognitive impairment affecting participation
- Unwilling to continue the intervention sessions
Read by machine on 12 November 2026.
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 25 and 75 years old?
Source: NCT07615257, who can take part
Where in Pakistan
- Department of Dermatologist Sheikh Zayed Hospital Rahim Yar KhanRahim Yar Khan, PakistanContact: Arslan Khalid, Assistant Professor IUBTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorTrial details
- Who runs it
- Islamia University of Bahawalpur
- Trial code
- NCT07615257
- Record updated
- 29 May 2026
- Original description
Your research study is about evaluating the effectiveness of **Mindfulness-Based Cognitive Therapy (MBCT)** in reducing psychological distress among psoriasis patients and improving their self-compassion and Mental Health Locus of Control (MHLC).Read full original descriptionShow less
Managing Psychological Distress Through Mindfulness-based CBT to Evaluate Its Effectiveness on Self-compassion Among Psoriasis Patients:The Mediating Role of Mental Health Locus of Control
Your research study is about evaluating the effectiveness of **Mindfulness-Based Cognitive Therapy (MBCT)** in reducing psychological distress among psoriasis patients and improving their self-compassion and Mental Health Locus of Control (MHLC).
The study highlights that psoriasis patients often suffer not only from physical symptoms but also from psychological problems such as stress, anxiety, depression, self-judgment, and low self-compassion. Traditional treatments mainly focus on physical symptoms and may not fully address these emotional and psychological difficulties.
To address this gap, the study proposes MBCT as a psychological intervention that combines mindfulness practices with cognitive therapy techniques. MBCT helps patients become more self-aware, reduce negative thinking, and develop self-compassion without self-judgment. The research also explores MHLC, which refers to how much control individuals believe they have over their health outcomes.
The study aims to investigate whether MBCT can:
* Reduce psychological distress, anxiety, depression, and stress levels * Improve self-compassion among psoriasis patients * Shift patients' locus of control from external to internal * Enhance emotional well-being and coping mechanisms
The research follows a quantitative experimental design conducted in phases. Initially, baseline levels of distress, MHLC, and self-compassion will be assessed. Later, MBCT interventions will be implemented and evaluated for effectiveness.
Overall, the study seeks to contribute to integrated psoriasis care by emphasizing the importance of psychological health alongside physical treatment, ultimately improving patients' quality of life and therapeutic outcomes.
Inclusion: Diagnosed psoriasis patients; Age between 18 and 65 years; Both male and female participants; Participants willing to provide informed consent; Participants experiencing psychological distress.
Exclusion: Patients currently receiving other psychological therapies; Patients with severe psychiatric disorders; Patients with serious medical or neurological conditions; Patients with cognitive impairment affecting participation; Under the age of 18 years will be excluded; Participants unwilling to continue the intervention sessions.